Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 2—February 2009


Seoul Virus and Hantavirus Disease, Shenyang, People’s Republic of China

Yong-Zhen ZhangComments to Author , Xue Dong, Xin Li, Chao Ma, Hai-Ping Xiong, Guang-Jie Yan, Na Gao, Dong-Mei Jiang, Ming-Hui Li, Lu-Ping Li, Yang Zou, and Alexander Plyusnin
Author affiliations: Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China (Y.-Z. Zhang, C. Ma, H.-P. Xiong, N. Gao, Y. Zou); Shenyang Center for Disease Control and Prevention, Shenyang, People’s Republic of China (X. Dong, X. Li, M.-H. Li); Shenhe District Center for Disease Control and Prevention, Shenyang (G.-J. Yan, D.-M. Jiang); Shenyang Infectious Disease Hospital, Shenyang (L.-P. Li); Haartman Institute, University of Helsinki, Helsinki, Finland (A. Plyusnin)

Main Article

Table 2

Serologic analysis of samples from HFRS patients by indirect IFA, Shenyang, China, 2006*

Serum sample no. IgM assay†
IgG assay†
1/06 40 20 640 160
2/06 40 20 320 80
3/06 40 320 80
4/06 20 320 160
5/06 40 320 80
6/06 40 20 160 20
7/06 40 20 320 80
8/06 40 320 160

*HFRS, hemorraghic fever with renal syndrome; IFA, immunofluorescent assay; Ig, immunoglobulin; SEOV, Seoul virus; HTNV, hantaan virus; –, could not be detected.
†Numbers represent the endpoint titers of anti-hantavirus (SEOV or HTNV) antibodies in the patients’ serum samples.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO